Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer

Autor: Wu, Yi-Long, Lu, Shun, Lu, You, Zhou, Jianying, Shi, Yuan-kai, Sriuranpong, Virote, Ho, James C.M., Ong, Choo Khoon, Tsai, Chun-Ming, Chung, Chin-Hee, Wilner, Keith D., Tang, Yiyun, Masters, Elizabeth T., Selaru, Paulina, Mok, Tony S.
Zdroj: In Journal of Thoracic Oncology October 2018 13(10):1539-1548
Databáze: ScienceDirect